technologynetworks

The Staying Power of Chromosomal Microarray Analysis: Innovations on the Horizon Will Future Proof Tried and True Technology

Genetic research labs are under constant pressure to increase their throughput while bringing down costs. Even though emerging new technologies can help labs expand their analysis capabilities, it’s ...
Nature

Is it time to report carrier state for recessive disorders in every microarray analysis?—A pilot model based on hearing loss genes deletions

Chromosomal Microarray Analysis (CMA) is currently the test of choice in patients with neurodevelopmental disorders and/or congenital anomalies, as well as in fetuses with structural aberrations [1].
Labroots

Faster workflow and improved coverage for copy number analysis

Introducing the new CytoScan HD Accel microarray that significantly improves the power and speed of genome-wide copy number analysis using industry-leading Chromosomal Microarray (CMA). The highly ...